Enable Injections Appoints David Kroekel as Chief Operating Officer

Enable Injections, Inc. Pennsylvania Ohio

and launch of the Company's first enFuse combination product.

Enable is currently working with a number of pharma partners to conduct clinical trials and planning for joint commercial launch of their therapies in combination with the enFuse technology. The Company continues to selectively add to its list of pharmaceutical partners, with indications and patient populations who will benefit from the enFuse system.

About Enable Injections
Cincinnati-based Enable Injections is a global healthcare innovation company developing and manufacturing drug delivery systems designed to improve the patient experience. Enable's body-worn enFuse® delivers high-volume pharmaceutical and biologic therapeutics via subcutaneous administration, with the aim of improving convenience, supporting superior outcomes, and advancing healthcare system economics. Approved in the United States in combination with a specific drug, more information: https://enableinjections.com/our-products.

Photo - https://mma.prnewswire.com/media/2336039/Enable_appoint_David_Kroekel_as_COO.jpg 
Logo - https://mma.prnewswire.com/media/962405/Enable_Injections_Logo.jpg

 

View original content:https://www.prnewswire.co.uk/news-releases/enable-injections-appoints-david-kroekel-as-chief-operating-officer-302056044.html